Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

247 requests
Make a request to this authority
Funding and Fees from Pfizer
Response by Medicines and Healthcare products Regulatory Agency to Georgina Goulding on .

Awaiting classification.

Dear Ms Goulding,         Thank you for your FOI request. Please can you clarify if you are referring to Pfizer Limited in the UK, Pfizer Inc in the...
Cases of uveitis, iritis and macular oedema following vaccination
Response by Medicines and Healthcare products Regulatory Agency to R Legal on .

Awaiting classification.

Our Ref: FOI 18/388 Dear Enquirer, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 20 July...
Adverse reactions to Seasonal Flu Vaccine. Enzira/ Pfizer from 2008-2018
Response by Medicines and Healthcare products Regulatory Agency to R Legal on .

Awaiting classification.

Dear R Legal, Thank you for your enquiry, please see the attached documents. Kind Regards Vigilance and Risk Management of Medicines Division Medic...
Yellow Card reports - Olanzapine and Risperidone
Response by Medicines and Healthcare products Regulatory Agency to Spencer on .

Awaiting classification.

Our Ref: FOI 18/384 Dear Spencer, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 19 July...
Henoch Schonlein Purpura links to Meningitis ACWY Vaccine and/or other causes
Response by Medicines and Healthcare products Regulatory Agency to Heidi Porter on .

Awaiting response.

Dear Heidi Porter, Thank you for your email which we have referred onward for consideration. We will respond to you as soon as possible. The referenc...
Adverse reactions reported by Sandyford Surgery, Glasgow
Response by Medicines and Healthcare products Regulatory Agency to R Legal on .

Awaiting classification.

Our Ref: FOI 18/376         Dear Enquirer,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000         Thank you for your enquiry which...
GCMAF enquiry
Response by Medicines and Healthcare products Regulatory Agency to Marcus flynn on .

Awaiting classification.

FOI 18/483 Dear Marcus Flynn, Thank you for your email of 19 June 2018 where you have stated " Im writing because its come to attention of many that...
Manufacturing of liothyronine tablets in the UK
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Awaiting classification.

Dear Ms Sanday,   Thank you for your communication dated 19 June 2018, where you requested information regarding liothyronine. Please find our res...
MHRA Haem Files
Response by Medicines and Healthcare products Regulatory Agency to JJ Evans on .

Successful.

Dear Mr Evans Please find attached a reply to your FOI request from 11^th June 2018, assigned reference number FOI 18/315.     Regards    ...
Did MHRA Benefit From The Ban On Co-proxamol?
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Successful.

FOI 18/197 Dear Mr Kelly, Thank you for your email. Please find attached the response to your Internal review. Kind Regards, Customer Services...
Aluminium in brain tissue in autism
Response by Medicines and Healthcare products Regulatory Agency to Nicholas Wells on .

Awaiting response.

Our Ref: FOI 18/360         Dear Mr Wells,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000         Thank you for your enquiry which...
Did MHRA in 2017 grant full licences to manufacture Liothyronine to Morningside and Teva?
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Ms Sanday,   Thank you for your recent FOI request regarding liothyronine. Please find our response attached.   Kind regards,   Medi...
How many reports have you had linking the HPV Vaccine to alopecia?
Request to Medicines and Healthcare products Regulatory Agency by ben harper. Annotated by jaya kamath on .

Partially successful.

Dear Mr. Harper, Came across this post, my 13 year old daughter who received HPV vaccination few months ago has started developing sudden onset of alo...
Alerts for Psychiatric drugs
Response by Medicines and Healthcare products Regulatory Agency to susanne stevens on .

Information not held.

FOI 18/255 Dear Ms Stevens, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Comm...
MHRA Factor Files
Response by Medicines and Healthcare products Regulatory Agency to JJ Evans on .

Long overdue.

Our reference: FOI 18/231 and 232 Dear Mr Evans, Thank you for your emails of 8 May to the Agency and NIBSC in which you asked for information about...
MMR vaccine adverse reactions
Response by Medicines and Healthcare products Regulatory Agency to Shelleyann on .

Successful.

FOI 18/203 Dear Ms Rimmer, Thank you for your email. Please find attached the response to your FOI request. Kind Regards, Customer Services...
Animal research
Response by Medicines and Healthcare products Regulatory Agency to Eithne Gallagher on .

Awaiting classification.

FOI 18/136 Dear Ms Gallagher, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Comm...
FOI Request - Complaints against slimming aids for calendar year 2017
Response by Medicines and Healthcare products Regulatory Agency to Rhiannondavies on .

Partially successful.

5^th April 2018 Rhiannon Davies [1][FOI #469135 email]   Dear Requestor,   REF:  FOI 18/114   Thank you for your communication to the M...
Domain suspension requests
Response by Medicines and Healthcare products Regulatory Agency to Open Rights Group on .

Refused.

  4^th April 2018   Dear Mr Killock         Thank you for your email.   Please find your internal review attached.          Kind Re...
Number of adverse incident reports for implantable Mesh and who reported
Response by Medicines and Healthcare products Regulatory Agency to Karen Preater on .

Successful.

MHRA reference: FOI 18/075 Dear Ms Preater, Thank you for your email of 17 March 2018 asking for clarification on our previous reply. We can confirm...
Documents for manufacturing of Liothyronine.
Response by Medicines and Healthcare products Regulatory Agency to Kathryn Potter on .

Successful.

Dear Kathryn Potter,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 11 February 2...
Comparison of MHRA revised standards for Liothyronine manufacture with those of other regulators
Response by Medicines and Healthcare products Regulatory Agency to Mike Maguire on .

Successful.

Dear Mr Maguire,         Thank you for your email.   Please find attached the response to your FOI request which was sent to you on 7^th March...
Liothyronine Concordia
Response by Medicines and Healthcare products Regulatory Agency to helga Wright on .

Successful.

Dear Helga Wright,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 10 February and...
Concordia International 6000% increase in price of Liothyronine tablets
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Linda Sanday,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 6 Februar...
How does the MHRA monitor Liothyronine T3 manufacturers' quality control
Response by Medicines and Healthcare products Regulatory Agency to Mike Maguire on .

Successful.

Dear Mr Maguire,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 12 February and 1...

Only requests made using WhatDoTheyKnow are shown. ?